Page 2 - Nasdaq Clbs News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Wall Street analysts expect Caladrius Biosciences, Inc. (NASDAQ:CLBS – Get Rating) to report earnings of ($0.12) per share for the current fiscal quarter, according to Zacks. Zero analysts have issued estimates for Caladrius Biosciences’ earnings, with estimates ranging from ($0.12) to ($0.11). Caladrius Biosciences reported earnings per share of ($0.19) in the same quarter last […]

StockNews.com initiated coverage on shares of Caladrius Biosciences (NASDAQ:CLBS – Get Rating) in a research note issued to investors on Sunday. The firm set a “sell” rating on the biotechnology company’s stock. Separately, HC Wainwright cut their price objective on Caladrius Biosciences from $8.00 to $6.00 and set a “buy” rating for the company in […]

Analysts expect that Caladrius Biosciences, Inc. (NASDAQ:CLBS – Get Rating) will announce ($0.15) earnings per share (EPS) for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have provided estimates for Caladrius Biosciences’ earnings. The lowest EPS estimate is ($0.16) and the highest is ($0.13). Caladrius Biosciences posted earnings per share of ($0.28) […]